Prosurvival and Chemoprotective Effects of Tumor-Associated Macrophages Reversed By Anti-CSF-1R Monoclonal Antibody in B-Cell Lymphomas

被引：0
|
作者：
Gopisetty, Anupama [1 ]
Foglietta, Myriam [2 ]
Zhang, Min [3 ]
Wang, Zhiqiang [3 ]
Fowler, Nathan [3 ]
Davis, Richard E. [3 ]
Neelapu, Sattva S. [3 ]
机构：
[1] MD Andeson Canc Ctr, Houston, TX USA
[2] Univ Turin, Citta Salute & Sci Torino, Turin, Italy
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] High Expression of CSF-1R Predicts Poor Prognosis and CSF-1Rhigh Tumor-Associated Macrophages Inhibit Anti-Tumor Immunity in Colon Adenocarcinoma
    Wang, Xingchao
    Zhang, Jianfeng
    Hu, Baoying
    Qian, Fei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] Novel CSF1R inhibitor, FF-10101, strongly inhibit tumor-associated macrophages and improve anti-tumor response
    Sato, Takahiko
    Sugiyama, Daisuke
    Kojima, Yasuhiro
    Hattori, Satomi
    Sone, Kazuki
    Ishikawa, Yuichi
    Nishikawa, Hiroyoshi
    Kiyoi, Hitoshi
    CANCER SCIENCE, 2024, 115 : 41 - 41
  • [23] INVITRO TESTS THAT PREDICT TUMOR-ASSOCIATED IDIOTYPE LEVELS IN THE SERUM OF PATIENTS WITH B-CELL LYMPHOMAS AND LEUKEMIAS
    MILLER, RA
    LOWDER, JN
    GRALOW, J
    MEEKER, T
    LEVY, R
    BLOOD, 1987, 69 (04) : 1249 - 1254
  • [24] MONOCLONAL ANTI-IDIOTYPIC ANTIBODY MIMICS TUMOR-ASSOCIATED SMALL CELL-CARCINOMA ANTIGEN
    BARTH, A
    WAIBEL, R
    STAHEL, RA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 413 - 413
  • [25] Therapeutic Effects of Anti-CD115 Monoclonal Antibody in Mouse Cancer Models through Dual Inhibition of Tumor-Associated Macrophages and Osteoclasts
    Fend, Laetitia
    Accart, Nathalie
    Kintz, Jacqueline
    Cochin, Sandrine
    Reymann, Carine
    Le Pogam, Fabrice
    Marchand, Jean-Baptiste
    Menguy, Thierry
    Slos, Philippe
    Rooke, Ronald
    Fournel, Sylvie
    Bonnefoy, Jean-Yves
    Preville, Xavier
    Haegel, Helene
    PLOS ONE, 2013, 8 (09):
  • [26] The advantage of residualizing radiolabels for targeting B-cell lymphomas with a radiolabeled anti-CD22 monoclonal antibody
    Mattes, MJ
    Shih, LB
    Govindan, SV
    Sharkey, RM
    Ong, GL
    Xuan, H
    Goldenberg, DM
    INTERNATIONAL JOURNAL OF CANCER, 1997, 71 (03) : 429 - 435
  • [27] CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer
    Lv, Qi
    Zhang, Yishu
    Gao, Wen
    Wang, Juan
    Hu, Yaowen
    Yang, Hongqiong
    Xie, Ying
    Lv, Yingshan
    Zhang, Heyuan
    Wu, Dapeng
    Hu, Lihong
    Wang, Junwei
    PHARMACOLOGICAL RESEARCH, 2024, 202
  • [28] Modulating tumor-associated macrophages through CSF1R inhibition: a potential therapeutic strategy for HNSCC
    Chen, Kaiting
    Li, Xiaochen
    Dong, Shuyi
    Guo, Yu
    Luo, Ziyin
    Zhuang, Shi-Min
    Liu, Jie
    Liu, Tianrun
    Liao, Jing
    Wen, Weiping
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [29] Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages
    Zhu, Mingxuan
    Bai, Liangliang
    Liu, Xiaoxia
    Peng, Shaoyong
    Xie, Yumo
    Bai, Hong
    Yu, Huichuan
    Wang, Xiaolin
    Yuan, Ping
    Ma, Rui
    Lin, Jinxin
    Wu, Linping
    Huang, Meijin
    Li, Yingjie
    Luo, Yanxin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (12)
  • [30] TAS-115 attenuates tumor-associated macrophages and enhances sensitivity to anti-PD-1 monoclonal antibody in syngeneic mouse tumors
    Haruma, Tomonori
    Fujita, Hidenori
    Yamada, Yukari
    Fukaya, Satoshi
    Hashimoto, Akihiro
    Harada, Takafumi
    Suzuki, Takamasa
    Matsuo, Kenichi
    Utsugi, Teruhiro
    Iwasawa, Yoshikazu
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
12345